Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 133Brain Neoplasms 129Prostatic Neoplasms 108Neoplasm Metastasis 88Lung Neoplasms 74Carcinoma, Hepatocellular 71Pancreatic Neoplasms 69Breast Neoplasms 50Melanoma 44Carcinoma, Renal Cell 36Neoplasms 34Colorectal Neoplasms 26Squamous Cell Carcinoma of Head and Neck 25Glioblastoma 24Liver Neoplasms 20Head and Neck Neoplasms 17Small Cell Lung Carcinoma 15Sarcoma 13Kidney Neoplasms 13Glioma 12Urinary Bladder Neoplasms 10Recurrence 9Gliosarcoma 8Ovarian Neoplasms 7Central Nervous System Neoplasms 7Adenocarcinoma of Lung 7Adenocarcinoma 7Radiation Injuries 6Prostate Cancer Metastatic 6Neuroma, Acoustic 6

Interventions

sintilimab 1Radiotherapy 1Radiosurgery 1Exome 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Squamous Cell Carcinoma × Radiosurgery × Clear all
NCT06121505 2025-12-17

Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer

Sichuan University

Phase 2 Recruiting
114 enrolled

Lung Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡